Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid–season results

Richard Pebody; F. Warburton; Joanna Ellis; Nicholas Andrews; Catherine Thompson; B. Von Wissmann; Helen Green; S. Cottrell; J. Johnston; S. De Lusignan; C. Moore; R. Gunson; C. Robertson; J. McMenamin; Maria Zambon

doi:10.2807/1560-7917.ES2015.20.5.21025

Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid–season results

Richard Pebody^*, F. Warburton, Joanna Ellis, Nicholas Andrews, Catherine Thompson, B. Von Wissmann, Helen Green, S. Cottrell, J. Johnston, S. De Lusignan, C. Moore, R. Gunson, C. Robertson, J. McMenamin, Maria Zambon

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

93 Citations (Scopus)

Abstract

In 2014/15 the United Kingdom experienced circulation of influenza A(H3N2) with impact in the elderly. Midseason vaccine effectiveness (VE) shows an adjusted VE of 3.4% (95% CI: −44.8 to 35.5) against primary care consultation with laboratory-confirmed influenza and −2.3% (95% CI: −56.2 to 33.0) for A(H3N2). The low VE reflects mismatch between circulating viruses and the 2014/15 northern hemisphere A(H3N2) vaccine strain. Early use of antivirals for prophylaxis and treatment of vulnerable populations remains important.

Original language	English
Pages (from-to)	1-7
Number of pages	7
Journal	Eurosurveillance
Volume	20
Issue number	5
DOIs	https://doi.org/10.2807/1560-7917.ES2015.20.5.21025
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2807/1560-7917.ES2015.20.5.21025

Cite this

Pebody, R., Warburton, F., Ellis, J., Andrews, N., Thompson, C., Wissmann, B. V., Green, H., Cottrell, S., Johnston, J., De Lusignan, S., Moore, C., Gunson, R., Robertson, C., McMenamin, J., & Zambon, M. (2015). Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid–season results. Eurosurveillance, 20(5), 1-7. https://doi.org/10.2807/1560-7917.ES2015.20.5.21025

@article{ce59fd1e0e744fcfb952fc0e1e38dc5d,

title = "Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid–season results",

abstract = "In 2014/15 the United Kingdom experienced circulation of influenza A(H3N2) with impact in the elderly. Midseason vaccine effectiveness (VE) shows an adjusted VE of 3.4% (95% CI: −44.8 to 35.5) against primary care consultation with laboratory-confirmed influenza and −2.3% (95% CI: −56.2 to 33.0) for A(H3N2). The low VE reflects mismatch between circulating viruses and the 2014/15 northern hemisphere A(H3N2) vaccine strain. Early use of antivirals for prophylaxis and treatment of vulnerable populations remains important.",

author = "Richard Pebody and F. Warburton and Joanna Ellis and Nicholas Andrews and Catherine Thompson and Wissmann, {B. Von} and Helen Green and S. Cottrell and J. Johnston and {De Lusignan}, S. and C. Moore and R. Gunson and C. Robertson and J. McMenamin and Maria Zambon",

year = "2015",

doi = "10.2807/1560-7917.ES2015.20.5.21025",

language = "English",

volume = "20",

pages = "1--7",

journal = "Eurosurveillance",

issn = "1025-496X",

publisher = "European Centre for Disease Prevention and Control (ECDC)",

number = "5",

}

Pebody, R, Warburton, F, Ellis, J, Andrews, N , Thompson, C, Wissmann, BV, Green, H, Cottrell, S, Johnston, J, De Lusignan, S, Moore, C, Gunson, R, Robertson, C, McMenamin, J & Zambon, M 2015, 'Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid–season results', Eurosurveillance, vol. 20, no. 5, pp. 1-7. https://doi.org/10.2807/1560-7917.ES2015.20.5.21025

TY - JOUR

T1 - Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom

T2 - 2014/15 mid–season results

AU - Pebody, Richard

AU - Warburton, F.

AU - Ellis, Joanna

AU - Andrews, Nicholas

AU - Thompson, Catherine

AU - Wissmann, B. Von

AU - Green, Helen

AU - Cottrell, S.

AU - Johnston, J.

AU - De Lusignan, S.

AU - Moore, C.

AU - Gunson, R.

AU - Robertson, C.

AU - McMenamin, J.

AU - Zambon, Maria

PY - 2015

Y1 - 2015

N2 - In 2014/15 the United Kingdom experienced circulation of influenza A(H3N2) with impact in the elderly. Midseason vaccine effectiveness (VE) shows an adjusted VE of 3.4% (95% CI: −44.8 to 35.5) against primary care consultation with laboratory-confirmed influenza and −2.3% (95% CI: −56.2 to 33.0) for A(H3N2). The low VE reflects mismatch between circulating viruses and the 2014/15 northern hemisphere A(H3N2) vaccine strain. Early use of antivirals for prophylaxis and treatment of vulnerable populations remains important.

AB - In 2014/15 the United Kingdom experienced circulation of influenza A(H3N2) with impact in the elderly. Midseason vaccine effectiveness (VE) shows an adjusted VE of 3.4% (95% CI: −44.8 to 35.5) against primary care consultation with laboratory-confirmed influenza and −2.3% (95% CI: −56.2 to 33.0) for A(H3N2). The low VE reflects mismatch between circulating viruses and the 2014/15 northern hemisphere A(H3N2) vaccine strain. Early use of antivirals for prophylaxis and treatment of vulnerable populations remains important.

UR - http://www.scopus.com/inward/record.url?scp=84922806328&partnerID=8YFLogxK

U2 - 10.2807/1560-7917.ES2015.20.5.21025

DO - 10.2807/1560-7917.ES2015.20.5.21025

M3 - Article

C2 - 602268014

AN - SCOPUS:84922806328

SN - 1025-496X

VL - 20

SP - 1

EP - 7

JO - Eurosurveillance

JF - Eurosurveillance

IS - 5

ER -

Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid–season results

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this